FDA UDI
In Commercial Distribution
🇺🇸 United States
N/A
DI: 00643169834330
·
Model: A521
·
MEDTRONIC, INC.
Product Codes
1
GMDN Terms
1
Identifiers
1
Pkg Device Count
1
Basic Information
- Brand Name
- N/A
- Primary DI
- 00643169834330
- Version / Model
- A521
- Company Name
- MEDTRONIC, INC.
- Labeler DUNS
- 796986144
- Distribution Status
- In Commercial Distribution
- Device Count in Pkg
- 1
- Record Status
- Published
- Publish Date
- 2018-01-14
- Public Version
- 5
- Public Version Date
- 2024-02-05
- Public Version Status
- Update
- Public Device Record Key
- b64a4cea-9022-4fc6-b9cf-3f1697e44197
Device Description
SW APP A521 GU PATIENT EVALUATION
Device Characteristics
- Single Use
- No
- Prescription Use (Rx)
- Yes
- Over the Counter (OTC)
- No
- Kit
- No
- Combination Product
- No
- HCT/P
- No
- Contains NRL
- No
- Not Made with NRL
- No
- MRI Safety
- Labeling does not contain MRI Safety Information
- Direct Marking Exempt
- No
- PM Exempt
- No
- Has Serial Number
- No
- Has Lot/Batch Number
- Yes
- Has Manufacturing Date
- No
- Has Expiration Date
- No
- Has Donation ID
- No
Sterilization
- Is Sterile
- No
- Sterilization Prior Use
- No
Product Codes
| Code | Name | Medical Specialty | Regulation # | Device Class |
|---|---|---|---|---|
| EZW | Stimulator, electrical, implantable, for incontinence | Gastroenterology, Urology | 876.5270 | 3 |
GMDN Terms
| Code | Name | Definition | Implantable | Status |
|---|---|---|---|---|
| 61395 | Wearable peripheral nerve electrical stimulator programmer | A portable, electrically-powered external device intended to wirelessly change one or more of the operating parameters (the programs) of a wearable peripheral nerve electrical stimulation system pulse generator. It may be a digital device which includes controls (e.g., graphical user interface), integrated software, and a wireless communication transmitter and receiver, or it may contain magnets of different field strengths that transmit commands when proximal to the stimulator. It is typically used during a trial period (<30 days) to validate the therapy. It is intended for use by both a clinician and a patient/layperson (under the guidance of a clinician) in a home or a clinical setting. | No | Active |
Identifiers
| Type | ID | Issuing Agency | Package Type | Qty per Pkg | Pkg Status | Pkg Discontinue Date |
|---|---|---|---|---|---|---|
| Primary | 00643169834330 | GS1 |
Customer Contacts
- Phone
- +1(800)633-8766
- [email protected]
Premarket Submissions
| Submission Number | Supplement Number |
|---|---|
| P080025 | 142 |
| P080025 | 197 |
| P970004 | 247 |
| P970004 | 302 |